Pharmacokinetics and toxicity of intrathecal liposomal cytarabine in children and adolescents following age-adapted dosing (Q46091640)

http://europepmc.org/abstract/MED/24129691

19 December 2017

title

Pharmacokinetics and toxicity of intrathecal liposomal cytarabine in children and adolescents following age-adapted dosing (English)

1 reference

http://europepmc.org/abstract/MED/24129691

19 December 2017

1 reference

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24129691%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Amedeo A Azizi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24129691%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Martina Höferl

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24129691%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Andreas Peyrl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24129691%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Robert Sauermann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24129691%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Walter Jäger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24129691%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Irene Slavc

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24129691%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

1 February 2014

1 reference

http://europepmc.org/abstract/MED/24129691

19 December 2017

published in

Clinical Pharmacokinetics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24129691%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24129691%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

165-173

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24129691%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24129691%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s40262-013-0106-1

2 June 2020

exact match

0 references

cites work

Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0106-1

Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0106-1

Pharmacokinetics and safety of intrathecal liposomal cytarabine in children aged <3 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0106-1

Intrathecal liposomal cytarabine in children under 4 years with malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0106-1

Safety and toxicity of intrathecal liposomal cytarabine (Depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0106-1

Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0106-1

Antiangiogenic metronomic therapy for children with recurrent embryonal brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0106-1

Intracranial volume change in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0106-1

Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0106-1

Neurologic complications of intrathecal liposomal cytarabine administered prophylactically to patients with non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0106-1

Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0106-1

Ventricular volume change in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0106-1

Extended CSF cytarabine exposure following intrathecal administration of DTC 101.

21 January 2018

1 reference

12 December 2020

Cytosine arabinoside cerebrospinal fluid kinetics

1 reference

12 December 2020

Influence of dose and duration of exposure on the cytotoxic effect of cytarabine toward human hematopoietic clonogenic cells

1 reference

12 December 2020

Neurologic complications after intrathecal liposomal cytarabine in combination with systemic polychemotherapy in primary CNS lymphoma

1 reference

12 December 2020

The effect of-beta-D-arabinofuranosylcytosine on growth, viability, and DNA synthesis of mouse L-cells

1 reference

12 December 2020

Liposomal cytarabine for central nervous system embryonal tumors in children and young adults

1 reference

12 December 2020

10.1007/S40262-013-0106-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24129691%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference